New: Introducing the Finviz Crypto Map

Learn More

CFRA Affirms 'Buy' Stance on Coca-Cola Co (KO) as Q2 Results Top Estimates

By Neha Gupta | July 31, 2025, 12:24 AM

The Coca-Cola Company (NYSE:KO) is one of the defensive stocks that billionaires are buying amid US trade tariff uncertainty. On July 22, analysts at CFRA reiterated a ‘Buy’ rating and an $80 price target on the stock. The positive stance comes from the company delivering solid second-quarter results that topped analyst estimates.

CFRA Affirms ‘Buy’ Stance on Coca-Cola Co (KO) as Q2 Results Top Estimates
urbanbuzz / Shutterstock.com

The beverage giant posted adjusted earnings per share of $0.87, representing a 4% year-over-year increase. It also topped consensus estimates of $0.84. The better-than-expected earnings were driven by solid gross margins that expanded to 62.4%.

The Coca-Cola Company (NYSE:KO) also recorded a 1.4% year-over-year increase in sales to $12.54 billion. The sales increase was driven by a positive price mix, which contributed to a 65% sales growth, offsetting the impact of currency headwinds. Coca-Cola also raised its full-year adjusted earnings per share to $3.04 from $3 for 2025 and to $3.20 from $3.15 for 2026.

The CFRA Buy rating is in response to the company’s global brand value, which is diminishing due to currency headwinds, and confidence in dividend aristocrat trends.

The Coca-Cola Company (NYSE:KO) is a global beverage company that manufactures, markets, and sells beverage concentrates and syrups, as well as finished beverages. Its products include a wide range of sparkling soft drinks, waters, juices, value-added dairy, and plant-based beverages.

While we acknowledge the potential of KO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 11 Best 52-Week High Stocks to Buy Now and 10 Best Biotech Stocks to Buy According to Billionaire Steve Cohen.

Disclosure: None. This article is originally published at Insider Monkey.

Mentioned In This Article

Latest News